CICILY JONES: Open Payments
NPI 1255396511 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,619 in 136 payments from 24 companies in 2025. Trend: 2023 $1,144 · 2024 $1,526 · 2025 $2,619
Food & beverage: $2,619
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 33 | $703 |
| AstraZeneca Pharmaceuticals LP | 16 | $481 |
| Kowa Pharmaceuticals America, Inc. | 17 | $232 |
| Novo Nordisk Inc | 13 | $218 |
| ABBVIE INC. | 10 | $187 |
| Amgen Inc. | 11 | $148 |
| GlaxoSmithKline, LLC. | 6 | $101 |
| Abbott Laboratories | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
Products named: MOUNJARO, AIRSUPRA, ZORYVE, VRAYLAR, Ozempic, FARXIGA, ZEPBOUND, OTEZLA.
Industry payments across IL — which companies pay providers there.
